David R. Holmes Jr, MD; J. Matthew Brennan, MD, MPH; John S. Rumsfeld, MD, PhD; et al.
In this follow-up study of a US registry of patients undergoing transcatheter aortic valve replacement, 1-year outcomes included overall mortality of 23.7%, stroke rate of 4.1%, and a composite of death and stroke of 26.0%.